Abbott Structural Heart Device Registry | MicrobiomeTrials← Back to trialsNCT06590467
Abbott Structural Heart Device Registry
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-08-21Est. Completion: 2029-12
Enrollment target: 2,500 participants Locations- USC University Hospital, Los Angeles, California, United States
- MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- Baptist Hospital of Miami, Miami, Florida, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States
- Mount Sinai Hospital, New York, New York, United States
- New York Presbyterian Hospital/Cornell University, New York, New York, United States
- The Cleveland Clinic Foundation, Cleveland, Ohio, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- UPMC, Pittsburgh, Pennsylvania, United States
- Sentara Norfolk General Hospital, Norfolk, Virginia, United States
- University of Washington Medical Center, Seattle, Washington, United States
- Mayo Clinic Health System - Eau Claire Hospital, Inc., Eau Claire, Wisconsin, United States
- Odense University Hospital, Odense, Southern Denmark, Denmark
- Tartu University Hospital, Tartu, Tartu, Estonia
Other microbiome trials you might be interested in
Atrial Fibrillation (AF)
The goal of this clinical trial is to learn if the cardiac pulsed field ablation system, composed of the cardiac pulsed …
Multiple LocationsEst. completion Mar 2028
Insulin ResistanceObesity
Background:
Obesity and related illnesses cause at least 2.8 million deaths each year worldwide. Few treatments exist f…
Bethesda, United StatesEst. completion Mar 1, 2030
CHU Rennes, Pontchaillou, Rennes, Brittan, FranceHôpital Marie-Lannelongue, Le Plessis-Robinson, FranceHopital Haut Leveque, Pessac, FranceDeutsches Herzzentrum München des Freistaates Bayern, München, Bavaria, GermanyKlinikum Links der Weser, Bremen, Free Hanseatic City of Bremen, GermanyUniversitatsklinikum Jena, Jena, Germany, GermanyStädt. Klinikum Braunschweig gGmbH, Braunschweig, L Saxon, GermanyDeutsches Herzzentrum der Charité, Berlin, State of Berlin, GermanySchüchtermann-Schiller´sche Kliniken GmbH & Co. KG, Bad Rothenfelde, GermanyChildren's Health Ireland (CHI), Crumlin, Dublin, IrelandIRCCS Policlinico San Donato - Cardio, San Donato Milanese, Lombardy, ItalyPoliclinico San Donato, San Donato Milanese, Lombardy, ItalyA.O.U. Citta della Salute e della Scienza di Torino, Turin, Piedmont, ItalyAzienda Ospedaliero Universitaria Pisana, Pisa, Tuscany, ItalySlaskie Centrum Chorob Serca, Zabrze, Silesian Voivodeship, PolandHospital Infantil Sant Joan De Deu, Esplugues de Llobregat, Catalonia, SpainHospital Universitario Central de Asturias, Oviedo, Principality of Asturias, SpainHospital Virgen de Rocio, Seville, Spain, SpainHospital Universitario de la Paz - Pediatrico, Madrid, SpainRoyal Brompton Hospital, London, UK, United KingdomSt. Thomas Hospital, London, United KingdomPhase 2
Recruiting
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative NeoplasmAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia, Myelodysplasia-RelatedMyelodysplastic Syndrome
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific lab…
Birmingham, United StatesEst. completion May 15, 2029